Real world use of lanreotide in neuroendocrine tumors

BACKGROUND: Treatment for metastatic neuroendocrine tumors (NETs) is often with somatostatin analogues (SSA) such as lanreotide in the first-line setting. Real world use of lanreotide in Canada is not well studied. METHODS: We performed a retrospective chart review of 69 patients to study real world...

Descripción completa

Detalles Bibliográficos
Autores principales: Siddiqui, Zeba, Marginean, Horia, Leung, Macyn, Asmis, Timothy, Vickers, Michael, Goodwin, Rachel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331746/
https://www.ncbi.nlm.nih.gov/pubmed/37435213
http://dx.doi.org/10.21037/jgo-22-1182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331746/
https://www.ncbi.nlm.nih.gov/pubmed/37435213
http://dx.doi.org/10.21037/jgo-22-1182

Ejemplares similares